+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Expansion: Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • September 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5141005

Quick Summary:

In an ever-evolving global business landscape, informed decision-making is key to maintaining a competitive edge. To that end, understanding the projections, trends and key players in the thriving Cell Expansion Market can prove invaluable. Our comprehensive market research report, meticulously drafted and updated, offers you the insights necessary to stay ahead.

Estimated currently at US$25.8 Billion, the global Cell Expansion market is projected to surge to a value of US$77.5 Billion by 2030. Bolstered by segments such as Consumables—which itself is forecasted to hit US$38.1 Billion—you can leverage these insights for strategic planning. Moreover, with detailed geographical breakups, including growth forecasts for markets as diverse as the U.S. and China, you can align your focus to ensure maximum global impact. This report, featuring industry giants such as Beckman Coulter, Inc. and GE Healthcare, among others, provides one-stop guidance for your foray into the proliferating Cell Expansion sector.

Global Cell Expansion Market to Reach $77.5 Billion by 2030

The global market for Cell Expansion estimated at US$25.8 Billion in the year 2022, is projected to reach a revised size of US$77.5 Billion by 2030, growing at a CAGR of 14.7% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 16% CAGR and reach US$38.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 12.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $7.8 Billion, While China is Forecast to Grow at 14% CAGR

The Cell Expansion market in the U.S. is estimated at US$7.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$13.1 Billion by the year 2030 trailing a CAGR of 14% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.6% and 11.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.

Select Competitors (Total 12 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Corning, Inc.
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KgaA
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Cell Expansion

What is the estimated value of the Global Market for Cell Expansion?

The Global Market for Cell Expansion was estimated to be valued at $25.8 Billion in 2022.

What is the growth rate of the Global Market for Cell Expansion?

The growth rate of the Global Market for Cell Expansion is 14.7%, with an estimated value of $77.5 Billion by 2030.

What is the forecasted size of the Global Market for Cell Expansion?

The Global Market for Cell Expansion is estimated to be worth $77.5 Billion by 2030.

Who are the key companies in the Global Market for Cell Expansion?

Key companies in the Global Market for Cell Expansion include Beckman Coulter, Inc., Becton, Dickinson and Company, Corning, Inc., GE Healthcare, Lonza Group Ltd., Merck KgaA, MilliporeSigma, Miltenyi Biotec GmbH, StemCell Technologies Inc. and Terumo BCT, Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Cell Expansion - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Human Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for Human Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Animal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 4: World 8-Year Perspective for Animal Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 6: World 8-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Cell Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World 8-Year Perspective for Cell Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 10: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 11: World Cell Expansion Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 12: World Recent Past, Current & Future Analysis for Cell Expansion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 13: World 8-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 15: World 8-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World 8-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 18: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 19: World 8-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 21: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 22: USA Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 23: USA 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 24: USA Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 25: USA 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: USA 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
CANADA
  • Table 28: Canada Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 29: Canada 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 30: Canada Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 31: Canada 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
JAPAN
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 34: Japan Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 35: Japan 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 36: Japan Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 37: Japan 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
CHINA
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 40: China Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 41: China 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 42: China Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 43: China 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: China 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
EUROPE
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 46: Europe Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 47: Europe 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 48: Europe Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 49: Europe 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Cell Expansion by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 51: Europe 8-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • Table 52: Europe Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 53: Europe 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
FRANCE
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 54: France Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 55: France 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: France 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 58: France Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 59: France 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
GERMANY
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 60: Germany Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 61: Germany 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 64: Germany Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 65: Germany 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
ITALY
  • Table 66: Italy Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 67: Italy 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 70: Italy Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 71: Italy 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
UNITED KINGDOM
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 72: UK Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 73: UK 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 75: UK 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 76: UK Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 77: UK 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
REST OF EUROPE
  • Table 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 79: Rest of Europe 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 81: Rest of Europe 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 82: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 83: Rest of Europe 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
ASIA-PACIFIC
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 85: Asia-Pacific 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 87: Asia-Pacific 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 89: Asia-Pacific 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
REST OF WORLD
  • Table 90: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 91: Rest of World 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of World 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 94: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 95: Rest of World 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Corning, Inc.
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KgaA
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.